Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.

Rivailler P, Carville A, Kaur A, Rao P, Quink C, Kutok JL, Westmoreland S, Klumpp S, Simon M, Aster JC, Wang F.

Blood. 2004 Sep 1;104(5):1482-9. Epub 2004 May 18.

PMID:
15150077
2.

Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.

Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.

J Med Virol. 2001 Sep;65(1):114-20.

PMID:
11505452
3.

Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.

Kutok JL, Klumpp S, Simon M, MacKey JJ, Nguyen V, Middeldorp JM, Aster JC, Wang F.

J Virol. 2004 Apr;78(7):3455-61.

4.

Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.

Sashihara J, Hoshino Y, Bowman JJ, Krogmann T, Burbelo PD, Coffield VM, Kamrud K, Cohen JI.

PLoS Pathog. 2011 Oct;7(10):e1002308. doi: 10.1371/journal.ppat.1002308. Epub 2011 Oct 20.

5.

An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Ohashi M, Fogg MH, Orlova N, Quink C, Wang F.

PLoS Pathog. 2012 Dec;8(12):e1003095. doi: 10.1371/journal.ppat.1003095. Epub 2012 Dec 27.

7.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

J Virol. 2005 Oct;79(19):12321-31.

8.

Non-human Primate Lymphocryptoviruses: Past, Present, and Future.

Mühe J, Wang F.

Curr Top Microbiol Immunol. 2015;391:385-405. doi: 10.1007/978-3-319-22834-1_13. Review.

PMID:
26428382
9.

Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Orlova N, Fogg MH, Carville A, Wang F.

Clin Vaccine Immunol. 2011 Sep;18(9):1427-34. doi: 10.1128/CVI.05126-11. Epub 2011 Jul 6.

10.
11.

Simian homologues of Epstein-Barr virus.

Wang F, Rivailler P, Rao P, Cho Y.

Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):489-97. Review.

12.

Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.

Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A.

Virology. 2006 Oct 10;354(1):192-206. Epub 2006 Jul 28.

13.

Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.

Moghaddam A, Koch J, Annis B, Wang F.

J Virol. 1998 Apr;72(4):3205-12.

14.

Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.

Marr-Belvin AK, Carville AK, Fahey MA, Boisvert K, Klumpp SA, Ohashi M, Wang F, O'Neil SP, Westmoreland SV.

Vet Pathol. 2008 Nov;45(6):914-21. doi: 10.1354/vp.45-6-914.

15.

Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Leskowitz R, Fogg MH, Zhou XY, Kaur A, Silveira EL, Villinger F, Lieberman PM, Wang F, Ertl HC.

J Virol. 2014 May;88(9):4721-35. doi: 10.1128/JVI.03744-13. Epub 2014 Feb 12.

16.

Nonhuman primate models for Epstein-Barr virus infection.

Wang F.

Curr Opin Virol. 2013 Jun;3(3):233-7. doi: 10.1016/j.coviro.2013.03.003. Epub 2013 Apr 3. Review.

17.

Experimental co-transmission of Simian Immunodeficiency Virus (SIV) and the macaque homologs of the Kaposi Sarcoma-Associated Herpesvirus (KSHV) and Epstein-Barr Virus (EBV).

Bruce AG, Barcy S, Staheli J, Bielefeldt-Ohmann H, Ikoma M, Howard K, Rose TM.

PLoS One. 2018 Nov 16;13(11):e0205632. doi: 10.1371/journal.pone.0205632. eCollection 2018.

19.

Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Herrman M, Mühe J, Quink C, Wang F.

J Virol. 2015 Nov 11;90(3):1222-30. doi: 10.1128/JVI.02531-15. Print 2016 Feb 1.

20.

Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.

Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA, Binley JM, Nixon DF, Connor RI.

J Gen Virol. 2005 Dec;86(Pt 12):3375-84.

PMID:
16298985

Supplemental Content

Support Center